NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 2 filers reported holding NOVELION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,000 | -3.4% | 39,891 | 0.0% | 0.00% | – |
| Q3 2019 | $29,000 | -6.5% | 39,891 | 0.0% | 0.00% | – |
| Q2 2019 | $31,000 | -36.7% | 39,891 | 0.0% | 0.00% | – |
| Q1 2019 | $49,000 | +44.1% | 39,891 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | -71.2% | 39,891 | 0.0% | 0.00% | – |
| Q3 2018 | $118,000 | -19.7% | 39,891 | 0.0% | 0.00% | – |
| Q2 2018 | $147,000 | +5.0% | 39,891 | 0.0% | 0.00% | – |
| Q1 2018 | $140,000 | +12.9% | 39,891 | 0.0% | 0.00% | – |
| Q4 2017 | $124,000 | -55.7% | 39,891 | 0.0% | 0.00% | – |
| Q3 2017 | $280,000 | -23.9% | 39,891 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $368,000 | -14.0% | 39,891 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $428,000 | +25.5% | 39,891 | -1.5% | 0.00% | 0.0% |
| Q4 2016 | $341,000 | – | 40,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 1,313,387 | $4,833,000 | 13.70% |
| Stonepine Capital Management, LLC | 1,792,911 | $6,598,000 | 4.01% |
| Broadfin Capital, LLC | 1,948,554 | $7,171,000 | 1.13% |
| Sarissa Capital Management LP | 1,025,000 | $3,772,000 | 0.76% |
| JW Asset Management, LLC | 315,979 | $1,163,000 | 0.74% |
| Prosight Management, LP | 194,663 | $716,000 | 0.52% |
| ARMISTICE CAPITAL, LLC | 1,856,000 | $6,830,000 | 0.45% |
| KNOTT DAVID M | 109,184 | $402,000 | 0.15% |
| EdgePoint Investment Group Inc. | 2,195,063 | $8,078,000 | 0.10% |
| Yakira Capital Management, Inc. | 36,428 | $134,000 | 0.03% |